All News

The credit crunch is strangling biotech. And with no access to capital, the only way out is to sell to big pharma.

As stock markets turn their backs on the high-risk sectors, France Biotech’s annual survey reveals the depths to which investment has fallen.

Europe’s biotechnology industry needs to speak with one voice and have a single, flagship gathering like the US’s annual BIO conference, says Eric Poincelet.

Who can deliver on science and innovation? I can, says the UK’s new Science Minister, Paul Drayson.

The European Commissioner for Science and Research gave a first progress report on the European Research Council at a meeting in Paris this week.

Sweden’s industrial development fund failed to sell any shares in portfolio companies in 2007–2008 and wrote down the value of its life sciences investments.